Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss

Osteoporosis is characterized by bone loss and destruction of trabecular architecture, which greatly increases the burden on the healthcare system. Excessive activation of osteoclasts is an important cause of osteoporosis, and suppression of osteoclastogenesis is helpful for the treatment of osteopo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Qi, Dahu, Liu, Hui, Sun, Xuying, Luo, Danni, Zhu, Meipeng, Tao, Tenghui, Gao, Chenghao, Zhou, Chuankun, Zhou, Wei, Xiao, Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7898668/
https://ncbi.nlm.nih.gov/pubmed/33628184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.621110
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky